Financials
- Market Capitalization 446 M
- Employee 674
- Founded 2013
- CEO Thomas Lingelbach
- Website www.valneva.com
- Headquarter France
- FIGI BBG00ZZPBH08
- Industry Biotechnologie
Related tickers
| # | Name | Preis | 24h % | 7d % | 1M % | 1J % | Marktkapitalisierung | Letzte 7 Tage | |
|---|---|---|---|---|---|---|---|---|---|
| 2989 | BNTC Benitec Biopharma Inc. - Common Stock | 12.99 USD | 0.00% | -3.35% | +14.25% | -21.79% | 446.26 M USD | ||
| 2993 | SLN Silence Therapeutics Plc - American Depository Share | 9.79 USD | +5.38% | -3.55% | +44.18% | +54.91% | 462.43 M USD | ||
| 3010 | EVMN Evommune, Inc. Common Stock | 12.00 USD | -0.91% | -8.33% | -40.06% | -30.72% | 432.22 M USD | ||
| 3011 | STRO Sutro Biopharma, Inc. - Common Stock | 25.99 USD | -6.65% | -19.11% | -9.76% | +49.45% | 430.67 M USD |